10Mar 2025
HPV Vaccination Reduces Actinic Keratosis Burden in Immunocompetent Patients

HPV Vaccination Reduces Actinic Keratosis Burden in Immunocompetent Patients

In the VAXAK trial, HPV vaccination significantly reduced the burden of actinic keratosis (AK) in immunocompetent adults with multiple lesions, showing a higher percentage reduction in AKs over 12 months compared to a sham vaccine. The vaccine also reduced the number of thick AKs. These findings suggest that HPV vaccines may be beneficial in managing AK, a common precursor to skin cancer.

  • #dermatology

Like

Save

Share